---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-025322"
form_type: "8-K/A"
ticker: "CCCC"
cik: "0001662579"
company_name: "C4 Therapeutics, Inc."
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T08:02:21.697121+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# C4 Therapeutics board adopts annual advisory vote on exec compensation after stockholder recommendation

## Summary
- Stockholders voted in favor of a 1-year frequency for advisory votes on named executive officer compensation.
- Board determined to hold annual non-binding advisory votes until the next required frequency proposal.
- Amendment filed solely to disclose this frequency decision; original 8-K reported June 22, 2022 annual meeting results.

## SEC filing metadata
- accession: 0001628280-22-025322
- form_type: 8-K/A
- ticker: CCCC
- cik: 0001662579
- company_name: C4 Therapeutics, Inc.
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/0001628280-22-025322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/cccc-20220622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-025322
- JSON: https://secwatch.observer/filing/0001628280-22-025322.json
- Plain text: https://secwatch.observer/filing/0001628280-22-025322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.